Scientists at the Max Planck Institute for Heart and Lung Research in Bad Nauheim have made a new discovery that could have a hugely positive impact on breast cancer treatment.
This particular form of the disease is the most common in Britain and Cancer Research UK statistics show that in 2008, 130 women were diagnosed with the condition every day.
However, a potential breakthrough in research could eventually lead to better preventative drugs hitting the market.
After conducting numerous studies on mice, the researchers believe that the spread of cancerous tumours around the body can be stopped by blocking the receptor protein Plexin-B1.
"We were able to establish a drastic reduction in the lung metastases in the animals without Plexin-B1. The effect could even be observed with the naked eye," commented leader of the research study Thomas Worzfeld.
The team are now hopeful that the findings will form the basis for the development of new drugs that suppress the emergence of metastases, although Mr Worzfield admitted that it could be a while before the antibody can be used in clinical practice.